The nation of Zimbabwe has turned down a significant American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years because of Washington's insistence on confidential biological samples.
This move came to light after a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the deal was "skewed".
An official spokesperson later explained that the US was requesting biological samples for research and commercial purposes but was unwilling to guarantee the benefits from any future medical innovations.
"We must now begin the difficult and regrettable task of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged more negotiations to find a agreement acceptable to all parties so the country's vital HIV programme can continue.
Wider Implications
This rejection comes after a similar case in Kenya, where a court halted a related deal with the US following concerns were filed about the safety of Kenyans' health data.
Since returning to the presidency recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
USAID had administered aid for the American government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral agreements to enhance openness and responsibility.
According to statements, 16 African countries have so far agreed to these new health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation could have provided immense benefits for the people of Zimbabwe, especially the 1.2 million currently on antiretroviral therapy through US-supported programmes," Tremont added.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, without any equivalent assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.
"Put simply, our nation would provide the basic resources for medical research without any certainty that the resulting innovations would be accessible to our population should a new health crisis emerge."
National Interest and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining systems previously set up via the international organization.
The spokesperson cited its Pandemic Benefit-Sharing framework created to deal with future global health emergencies.
"This framework is intended to ensure that when a nation contributes its information, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome continued discussions with our US partners on how future collaboration could be designed in a manner that respects the independence and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but recommended that negotiations must proceed since much of the country's Aids initiatives were funded by foreign aid.
"Where technical issues arise, such as those involving data governance or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," the group added.
The halted deal highlights the complex tensions between receiving crucial foreign assistance and protecting national sovereignty in an increasingly interconnected world.